Form 4: Amphastar Pharmaceuticals Director Lee Howard Reports Stock Transactions

Director Lee Howard reports acquisition and disposal of Amphastar Pharmaceuticals stock and stock options.

Summary

• On June 3, 2024, Director Lee Howard acquired 3,076 shares of common stock represented by restricted stock units (RSUs) that vest on June 3, 2025.
• On June 3, 2024, Lee Howard also acquired a stock option for 6,864 shares of common stock at an exercise price of $42.25, vesting on June 3, 2025 and expiring on June 3, 2034.
• On June 5, 2024, 579 shares of common stock were disposed of at $42.04 to cover tax liabilities related to the vesting of RSUs.
• Following these transactions, Lee Howard directly owns 147,777 shares of common stock and holds options for 6,864 shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the trading activities of company directors. It's common for executives to receive stock options and RSUs as part of their compensation packages, and their subsequent transactions are closely monitored by regulators and investors.

Stakeholder Impact

• Shareholders are informed about the stock transactions of a company director, which can influence their perception of the company's prospects.

Key Dates